{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:37:38Z","timestamp":1789011458453,"version":"build-2803163510"},"reference-count":34,"publisher":"Jaypee Brothers Medical Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.59556\/japi.72.0745","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:12:49Z","timestamp":1750659169000},"page":"e12-e15","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Depression in Patients with Epilepsy: A Single Center Cross-sectional Study at a Tertiary Care Hospital"],"prefix":"10.59556","volume":"72","author":[{"given":"Sriramakrishnan","family":"Vayanakkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anto Ignat","family":"Stany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Karunaharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20250623061243_B1","doi-asserted-by":"crossref","first-page":"388\u2013","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms and treatment.","volume":"54:","author":"Kanner","year":"2003;","journal-title":"Biol Psychiatry"},{"key":"key20250623061243_B2","first-page":"156\u2013","article-title":"Presence of depressive disorder among patients with epilepsy in relation to the duration of illness and type of antiepileptic therapy.","volume":"62:","author":"Mehmedika-Sulji","year":"2008;","journal-title":"Med Arh"},{"key":"key20250623061243_B3","doi-asserted-by":"crossref","first-page":"20\u2013","DOI":"10.1176\/jnp.17.1.20","article-title":"Mood disorder and their treatment in patients with epilepsy.","volume":"17:","author":"Prueter","year":"2005;","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key20250623061243_B4","doi-asserted-by":"crossref","first-page":"129\u2013","DOI":"10.1097\/01.wco.0000162853.29650.ec","article-title":"Diagnosis and treatment of mood disorders in persons with epilepsy.","volume":"18:","author":"Gillian","year":"2005;","journal-title":"Curr Opin Neurol"},{"key":"key20250623061243_B5","doi-asserted-by":"crossref","first-page":"75\u2013","DOI":"10.1111\/j.1600-0404.2008.01088.x","article-title":"Don\u2019t be afraid to treat depression in patients with epilepsy!","volume":"119:","author":"Kondziella","year":"2009;","journal-title":"Acta Neurol Scand"},{"key":"key20250623061243_B6","doi-asserted-by":"crossref","first-page":"1008\u2013","DOI":"10.1212\/01.WNL.0000138430.11829.61","article-title":"Depression and comorbidity in community-based patients with epilepsy or asthma.","volume":"63:","author":"Ettinger","year":"2004;","journal-title":"Neurology"},{"key":"key20250623061243_B7","doi-asserted-by":"crossref","first-page":"515\u2013","DOI":"10.1016\/j.yebeh.2003.07.009","article-title":"The in\ufb02uence of comorbid depression on quality of life for people with epilepsy.","volume":"4:","author":"Cramer","year":"2003;","journal-title":"Epilepsy Behav"},{"issue":"(6):","key":"key20250623061243_B8","doi-asserted-by":"crossref","first-page":"595\u2013","DOI":"10.1111\/j.1528-1157.1998.tb01427.x","article-title":"Symptoms of depression and anxiety in pediatric epilepsy patients.","volume":"39","author":"Ettinger","year":"1998;","journal-title":"Epilepsia"},{"issue":"(5):","key":"key20250623061243_B9","doi-asserted-by":"crossref","first-page":"720\u2013","DOI":"10.1111\/j.1528-1167.2005.43604.x","article-title":"Depression and anxiety disorders in pediatric epilepsy.","volume":"46","author":"Caplan","year":"2005;","journal-title":"Epilepsia"},{"key":"key20250623061243_B10","doi-asserted-by":"crossref","first-page":"56\u2013","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23:","author":"Hamilton","year":"1960;","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20250623061243_B11","doi-asserted-by":"crossref","first-page":"S31\u2013","DOI":"10.1111\/j.1528-1157.2000.tb01522.x","article-title":"Psychiatric comorbidity in chronic epilepsy: identi\ufb01cation, consequences, and treatment of major depression.","volume":"41:","author":"Hermann","year":"2000;","journal-title":"Epilepsia"},{"key":"key20250623061243_B12","doi-asserted-by":"crossref","first-page":"561\u2013","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4:","author":"Beck","year":"1961;","journal-title":"Arch Gen Psychiatry"},{"key":"key20250623061243_B13","first-page":"115\u2013","article-title":"The aetiologies of epilepsy in tropical Africa.","volume":"47:","author":"Adamolekun","year":"1995;","journal-title":"Trop Geogr Med"},{"issue":"(4):","key":"key20250623061243_B14","doi-asserted-by":"crossref","first-page":"512\u2013","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology.","volume":"58","author":"Scheffer","year":"2017;","journal-title":"Epilepsia"},{"issue":"(Suppl 1):","key":"key20250623061243_B15","first-page":"S16\u2013","article-title":"Effect of anticonvulsants on sleep.","volume":"54","author":"Sammaritano","year":"2000;","journal-title":"Neurology"},{"key":"key20250623061243_B16","first-page":"141\u2013","article-title":"Neurologic complications of AIDS and HIV infection: an overview.","volume-title":"A Clinician\u2019s Guide to AIDS and HIV Infection.","author":"Koppel","year":"1996;"},{"key":"key20250623061243_B17","doi-asserted-by":"crossref","first-page":"1404\u2013","DOI":"10.1212\/WNL.54.7.1404","article-title":"Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals.","volume":"54:","author":"Romanelli","year":"2000;","journal-title":"Neurology"},{"issue":"(suppl 9):","key":"key20250623061243_B18","first-page":"15.","article-title":"Predicting outcomes in newly diagnosed epilepsy.","volume":"44","author":"Mohanraj","year":"2003;","journal-title":"Epilepsia"},{"issue":"(Suppl 10):","key":"key20250623061243_B19","first-page":"S48\u2013","article-title":"Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.","volume":"40","author":"Pisani","year":"1999;","journal-title":"Epilepsia"},{"key":"key20250623061243_B20","doi-asserted-by":"crossref","first-page":"197\u2013","DOI":"10.1177\/030006059302100405","article-title":"Acute fluvoxamine poisoning.","volume":"21:","author":"Garnier","year":"1993;","journal-title":"J Int Med Res"},{"key":"key20250623061243_B21","doi-asserted-by":"crossref","first-page":"732.","DOI":"10.1176\/ajp.153.5.732a","article-title":"Seizure and transient SIADH associated with sertraline.","volume":"153:","author":"Goldstein","year":"1996;","journal-title":"Am J Psychiatry"},{"issue":"(Suppl 2):","key":"key20250623061243_B22","first-page":"S9\u2013","article-title":"Evidence supporting the temporal lobe epilepsy personality syndrome.","volume":"53","author":"Blumer","year":"1999;","journal-title":"Neurology"},{"issue":"(4):","key":"key20250623061243_B23","doi-asserted-by":"crossref","first-page":"565.","DOI":"10.4103\/0028-3886.68679","article-title":"Depressive symptoms in patients with epilepsy: analysis of self-rating and physician\u2019s assessment.","volume":"58","author":"Ogunrin","year":"2010;","journal-title":"Neurol India"},{"key":"key20250623061243_B24","doi-asserted-by":"crossref","first-page":"2115\u2013","DOI":"10.1212\/WNL.54.11.2115","article-title":"A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy.","volume":"54:","author":"Simpson","year":"2000;","journal-title":"Neurology"},{"issue":"(10):","key":"key20250623061243_B25","doi-asserted-by":"crossref","first-page":"1926\u2013","DOI":"10.1212\/WNL.45.10.1926","article-title":"Anticonvulsant effect of fluoxetine in humans.","volume":"45","author":"Favale","year":"1995;","journal-title":"Neurology"},{"issue":"(1):","key":"key20250623061243_B26","doi-asserted-by":"crossref","first-page":"13\u2013","DOI":"10.1016\/0887-8994(86)90033-0","article-title":"The use of imipramine in minor motor seizures.","volume":"2","author":"Hurst","year":"1986;","journal-title":"Pediatr Neurol"},{"key":"key20250623061243_B27","doi-asserted-by":"crossref","first-page":"571\u2013","DOI":"10.1007\/s11940-000-0035-9","article-title":"Depression in individuals with epilepsy.","volume":"2:","author":"Barry","year":"2000;","journal-title":"Current Treat Options Neurol"},{"key":"key20250623061243_B28","doi-asserted-by":"crossref","first-page":"215\u2013","DOI":"10.1056\/NEJM200001203420315","article-title":"Reboxetine and hyponatremia.","volume":"342:","author":"Ranieri","year":"2000;","journal-title":"N Engl J Med"},{"key":"key20250623061243_B29","doi-asserted-by":"crossref","first-page":"689\u2013","DOI":"10.1192\/bjp.162.5.689","article-title":"Lithium neurotoxicity at normal therapeutic levels.","volume":"162:","author":"Bell","year":"1993;","journal-title":"Br J Psychiatry"},{"key":"key20250623061243_B30","doi-asserted-by":"crossref","first-page":"S21\u2013","DOI":"10.1111\/j.1528-1157.1999.tb00884.x","article-title":"Depression in epilepsy: etiology, phenomenology, and treatment.","volume":"40:","author":"Lambert","year":"1999;","journal-title":"Epilepsia"},{"key":"key20250623061243_B31","first-page":"S26\u2013","article-title":"Depressive disorders in epilepsy.","volume":"53:","author":"Rivas Nieto","year":"1999;","journal-title":"Neurology"},{"key":"key20250623061243_B32","first-page":"S68\u2013","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations.","volume":"53:","author":"Alldredge","year":"1999;","journal-title":"Neurology"},{"key":"key20250623061243_B33","doi-asserted-by":"crossref","first-page":"1323\u2013","DOI":"10.1016\/S0006-2952(96)00509-6","article-title":"Antidepressants and seizures: clinical anecdotes overshadow neuroscience.","volume":"52:","author":"Dailey","year":"1996;","journal-title":"Biochem Pharmacol"},{"key":"key20250623061243_B34","doi-asserted-by":"crossref","first-page":"1069\u2013","DOI":"10.1016\/S0025-6196(12)61375-5","article-title":"Pharmacology of antidepressants\u2014characteristics of the ideal drug.","volume":"69:","author":"Richelson","year":"1994;","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:12:54Z","timestamp":1750659174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-11-e12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.59556\/japi.72.0745"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0745","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}